A significantly higher N-cadherin expression was demonstrated in SCC compared to BCC (p = 0.032), as there were 14% of SCC cases with more than 50% cells expressing N-cadherin, 10% with 26–50% and 8% with 1–25% expression. The gene discussed is CDH2; the disease is skin basal cell carcinoma.